Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO (finding)
|
3 | 0.525 | 0.800 | 4 | 153705165 | missense variant | G/A | snv | 1.7E-02 | 1.8E-02 | 0.700 | 0 | |||||||
Staphylococcal Infections
|
5 | 0.525 | 0.800 | 4 | 153705165 | missense variant | G/A | snv | 1.7E-02 | 1.8E-02 | 0.020 | 1.000 | 2 | 2000 | 2010 | ||||
Tuberculosis
|
328 | 0.525 | 0.800 | 4 | 153705165 | missense variant | G/A | snv | 1.7E-02 | 1.8E-02 | 0.100 | 1.000 | 11 | 2004 | 2019 | ||||
Periodontitis
|
116 | 0.525 | 0.800 | 4 | 153705165 | missense variant | G/A | snv | 1.7E-02 | 1.8E-02 | 0.020 | 0.500 | 2 | 2004 | 2010 | ||||
Chlamydia Infections
|
10 | 0.525 | 0.800 | 4 | 153705165 | missense variant | G/A | snv | 1.7E-02 | 1.8E-02 | 0.010 | 1 | 2004 | 2004 | |||||
Lupus Erythematosus, Systemic
|
1172 | 0.525 | 0.800 | 4 | 153705165 | missense variant | G/A | snv | 1.7E-02 | 1.8E-02 | 0.010 | 1.000 | 1 | 2004 | 2004 | ||||
Rheumatoid Arthritis
|
2387 | 0.525 | 0.800 | 4 | 153705165 | missense variant | G/A | snv | 1.7E-02 | 1.8E-02 | 0.010 | 1.000 | 1 | 2004 | 2004 | ||||
Rheumatic Fever
|
5 | 0.525 | 0.800 | 4 | 153705165 | missense variant | G/A | snv | 1.7E-02 | 1.8E-02 | 0.030 | 1.000 | 3 | 2005 | 2015 | ||||
Lyme Disease
|
4 | 0.525 | 0.800 | 4 | 153705165 | missense variant | G/A | snv | 1.7E-02 | 1.8E-02 | 0.020 | 1.000 | 2 | 2005 | 2015 | ||||
Generalized periodontitis
|
5 | 0.525 | 0.800 | 4 | 153705165 | missense variant | G/A | snv | 1.7E-02 | 1.8E-02 | 0.010 | 1.000 | 1 | 2005 | 2005 | ||||
Rheumatic fever in children
|
1 | 0.525 | 0.800 | 4 | 153705165 | missense variant | G/A | snv | 1.7E-02 | 1.8E-02 | 0.010 | 1.000 | 1 | 2005 | 2005 | ||||
Familial Mediterranean Fever
|
82 | 0.525 | 0.800 | 4 | 153705165 | missense variant | G/A | snv | 1.7E-02 | 1.8E-02 | 0.040 | 1.000 | 4 | 2006 | 2011 | ||||
AA amyloidosis
|
10 | 0.525 | 0.800 | 4 | 153705165 | missense variant | G/A | snv | 1.7E-02 | 1.8E-02 | 0.020 | 1.000 | 2 | 2006 | 2011 | ||||
Bacterial Infections
|
17 | 0.525 | 0.800 | 4 | 153705165 | missense variant | G/A | snv | 1.7E-02 | 1.8E-02 | 0.020 | 1.000 | 2 | 2006 | 2007 | ||||
Behcet Syndrome
|
243 | 0.525 | 0.800 | 4 | 153705165 | missense variant | G/A | snv | 1.7E-02 | 1.8E-02 | 0.020 | 0.500 | 2 | 2006 | 2009 | ||||
Reactive systemic amyloidosis
|
11 | 0.525 | 0.800 | 4 | 153705165 | missense variant | G/A | snv | 1.7E-02 | 1.8E-02 | 0.020 | 1.000 | 2 | 2006 | 2011 | ||||
Diabetes Mellitus, Insulin-Dependent
|
954 | 0.525 | 0.800 | 4 | 153705165 | missense variant | G/A | snv | 1.7E-02 | 1.8E-02 | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||
Inflammatory disorder
|
8 | 0.525 | 0.800 | 4 | 153705165 | missense variant | G/A | snv | 1.7E-02 | 1.8E-02 | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||
Osteomyelitis
|
14 | 0.525 | 0.800 | 4 | 153705165 | missense variant | G/A | snv | 1.7E-02 | 1.8E-02 | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||
Cytomegalovirus Infections
|
26 | 0.525 | 0.800 | 4 | 153705165 | missense variant | G/A | snv | 1.7E-02 | 1.8E-02 | 0.060 | 1.000 | 6 | 2007 | 2019 | ||||
Hepatitis C, Chronic
|
80 | 0.525 | 0.800 | 4 | 153705165 | missense variant | G/A | snv | 1.7E-02 | 1.8E-02 | 0.030 | 1.000 | 3 | 2007 | 2012 | ||||
Rheumatic Heart Disease
|
33 | 0.525 | 0.800 | 4 | 153705165 | missense variant | G/A | snv | 1.7E-02 | 1.8E-02 | 0.030 | 0.667 | 3 | 2007 | 2015 | ||||
Hepatitis C
|
347 | 0.525 | 0.800 | 4 | 153705165 | missense variant | G/A | snv | 1.7E-02 | 1.8E-02 | 0.020 | 1.000 | 2 | 2007 | 2010 | ||||
Mycobacterium Infections
|
14 | 0.525 | 0.800 | 4 | 153705165 | missense variant | G/A | snv | 1.7E-02 | 1.8E-02 | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||
Recurrent urinary tract infection
|
21 | 0.525 | 0.800 | 4 | 153705165 | missense variant | G/A | snv | 1.7E-02 | 1.8E-02 | 0.010 | 1.000 | 1 | 2007 | 2007 |